Quantitative Measurement of Disc Asymmetry in Glaucoma
Principal Investigator
Christopher Girkin, MD
University of Alabama at Birmingham
Birmingham, AL, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$50,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
G2000007
Summary
Dr. Girkin hopes to determine whether a new technology for analyzing the optic nerve can be used to measure glaucomatous damage. This technology, known as confocal scanning laser ophthalmoscopy (CSLO), has the potential to allow for earlier diagnosis and to more accurately assess the progression of the disease. The quantitative aspect of currently used techniques is limited because of the normal variations in optic disc structure that occur even in a healthy population. However, structural differences between the two eyes in a healthy individual appear to be small, and Dr. Girkin is seeking to determine if measuring these differences with CSLO can be used to control for normal variability. In other words, he will determine the amount of asymmetry in optic disc structure in healthy individuals and determine if there is significantly greater asymmetry between the eyes of glaucoma patients or patients with high intraocular pressure. This is possible because even though glaucoma typically occurs in both eyes, it often progresses more quickly in one eye than in the other.
Related Grants
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester